Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;52(9):849-859.
doi: 10.1111/jop.13467. Epub 2023 Aug 13.

Elevated translationally controlled tumour protein promotes oral cancer progression and poor outcome

Affiliations

Elevated translationally controlled tumour protein promotes oral cancer progression and poor outcome

Dipti Sharma et al. J Oral Pathol Med. 2023 Oct.

Abstract

Background: Translationally controlled tumour protein (TCTP) is a multifunctional protein elevated in multiple cancers. However, studies on its role in oral carcinogenesis and prognosis are rare. We recently reported the role of its interacting partner, MCL1, in oral cancer progression and outcome. Hence, the present study aimed to assess TCTP expression in oral tumorigenesis and its association with patient outcomes alone and in combination with MCL1.

Methods: TCTP expression was assessed by immunohistochemistry and immunoblotting in oral tissues and cells, respectively. Cell viability post siRNA/dihydroartemisinin treatment was analysed by tetrazolium salt assay. Cell survival, invasion and tumorigenic potential post TCTP knockdown were assessed by clonogenic, Matrigel and soft-agar assays, respectively. The association of TCTP with patient outcome was analysed by Kaplan-Meier and Cox regression.

Results: TCTP was significantly overexpressed in oral premalignant lesions (p < 0.0001), oral tumours (p < 0.0001) and oral dysplastic and cancer cells versus normal oral mucosa and also in recurrent (p < 0.05) versus non-recurrent oral tumours. Further, elevated TCTP was significantly (p < 0.05) associated with poor recurrence free survival (RFS) and poor overall survival (OS; hazard ratio = 2.29; p < 0.05). Intriguingly, the high co-expression of TCTP and MCL1 further reduced the RFS (p < 0.05) and OS (p < 0.05; hazard-ratio = 3.49; p < 0.05). Additionally, TCTP knockdown decreased survival (p < 0.05), invasion (p < 0.01) and in vitro tumorigenic potential (p < 0.0001). Dihydroartemisinin treatment reduced TCTP levels and viability of oral cancer cells.

Conclusion: Our studies demonstrate an oncogenic role of TCTP in oral cancer progression and poor outcome. Thus, TCTP may be a potential prognostic marker and therapeutic target in oral cancers.

Keywords: TCTP; invasion; oral squamous cell carcinoma; prognosis; recurrence.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Mohan P, Lando HA. Oral Tobaccco and mortality in India. Indian J Clin Med. 2016;7:IJCM.S25889. doi:10.4137/IJCM.S25889
    1. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14:47-62. doi:10.1177/154411130301400105
    1. de Oliveira LQR, Almangush A, Al-Samadi A, Salo T, Coletta RD. Prognostic markers for oral cancer: An overview of the current status and directions for future research. J Oral Pathol Med. 2023;52:288-293. doi:10.1111/jop.13406
    1. Tanaka T, Ishigamori R. Understanding carcinogenesis for fighting oral cancer. J Oncol. 2011;2011:603740. doi:10.1155/2011/603740
    1. Shetty KSR, Kurle V, Greeshma P, et al. Salvage surgery in recurrent oral squamous cell carcinoma. Front Oral Health. 2022;2:815606. doi:10.3389/froh.2021.815606

MeSH terms

Grants and funding

LinkOut - more resources